Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study

To explore if switching intravesical chemotherapeutic agents is beneficial in short-term recurrences of high-risk non-muscle-invasive bladder cancer (NMIBC) following the failure of preceding intravesical ther...

Source: BMC Urology - January 31, 2024 Category: Urology & Nephrology Authors: Shuaiqi Chen, Guangyu Sun, Xiaoxu Chen, Tiyara Salgado, Shangrong Wu, Hailong Hu, Ranlu Liu and Yunkai Qie Tags: Research Source Type: research